Zhen Pan

Director/Board Member at SHANGHAI GUIJIU CO.,LTD

41 year

Consumer Services

Consumer Non-Durables

Health Technology

Profile

Zhen Pan is currently working as a Director at Shanghai Guijiu Co., Ltd.
and as a Member-Supervisory Board at Hebei Yipin Pharmaceutical Co., Ltd.
He holds a Master's degree in Business Administration from Shanghai Jiao Tong University and an undergraduate degree from Shanghai University of Finance & Economics.

Zhen Pan active positions

Companies	Position	Start
SHANGHAI GUIJIU CO.,LTD	Director/Board Member	2021-08-31
Hebei Yipin Pharmaceutical Co., Ltd. Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China.	Director/Board Member	2021-02-28

All active positions of Zhen Pan

Training of Zhen Pan

Shanghai Jiao Tong University	Masters Business Admin
Shanghai University of Finance & Economics	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zhen Pan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SHANGHAI GUIJIU CO.,LTD	Consumer Non-Durables

Private companies	1
Hebei Yipin Pharmaceutical Co., Ltd. Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China.	Health Technology